CANTON, Mass. and SAN DIEGO, Oct. 27 /PRNewswire/ -- Organogenesis, Inc. Chief Medical Officer Dr. Damien Bates will speak on the first night of the prestigious TEDMED medical innovation conference beginning today in San Diego, Calif. Dr. Bates' speech "Where Does Replacement Skin Come From?" will outline developments in the emerging and promising field of Regenerative Medicine and discuss the transformation of patient lives.
The field of regenerative medicine has now reached the stage of translating groundbreaking science into viable product offerings. Organogenesis was the first company to successfully commercialize and mass produce living regenerative medicine products - reaching hundreds of thousands of patients in the U.S. and around the world. Its flagship product, Apligraf®, was the first regenerative medicine product to have received U.S. Food and Drug Administration (FDA) approvals to close both diabetic foot ulcers and venous leg ulcers.
Damien Bates, MD, PhD, FRACS (Plast.), is a practicing board certified plastic and reconstructive surgeon with over 12 years of clinical experience in both the U.S. and Australia. Dr. Bates holds an MD from the University of Sydney and a PhD in developmental biology from the University of Melbourne.
The fifth in a series created by Marc Hodosh and Richard Saul Wurman, TEDMED celebrates conversations that demonstrate the intersection and connections between all things medical and healthcare related: from personal health to public health, devices to design and Hollywood to the hospital. Together, this encompasses more than twenty percent of America's GNP while touching everyone's life around the globe. TEDMED 2009 will take place October 27-30 in San Diego, Calif. For more information, visit www.tedmed.com.
About Regenerative Medicine
A new frontier in healthcare, regenerative me
|SOURCE Organogenesis, Inc.|
Copyright©2009 PR Newswire.
All rights reserved